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Oxidized cytochrome c1 in photosynthetic bacterium Rhodobacter capsulatus cytochrome bc1 reversibly binds cyanide with surprisingly
high, micromolar affinity. The binding dramatically lowers the redox midpoint potential of heme c1 and inhibits steady-state turnover activity
of the enzyme. As cytochrome c1, an auxiliary redox center of the high-potential chain of cytochrome bc1, does not interact directly with the
catalytic quinone/quinol binding sites Qo and Qi, cyanide introduces a novel, Q-site independent locus of inhibition. This is the first report of
a reversible inhibitor that manipulates the energetics and electron transfers of the high-potential redox chain of cytochrome bc1, while
maintaining quinone substrate catalytic sites in an intact form.
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Quinonoid inhibitors have provided the traditional
means for teasing apart and isolating the string of
connected electron transfers within the cytochrome bc1.
They have revealed two distinct quinone/quinol binding
sites: stigmatellin and myxothiazol inhibited Qo at which
quinol is normally oxidized, and antimycin inhibited Qi, at
which quinone is normally reduced (Fig. 1) [1,2]. Further-
more, by displacing quinone at the binding sites in X-ray
crystallographic structures [3–8], they approximate the
position of the more loosely bound and so far unresolvable
quinol in the Qo site. However, unlike the reversible heme
ligand inhibitors used with great effect by Babcock and
others (for example see Ref. [9]), quinonoid inhibitors0005-2728/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbabio.2003.07.005
Abbreviations: CN, cyanide; cyt c1-CN, cytochrome c1 with bound
cyanide; Qo and Qi sites, quinol oxidation and quinone reduction sites of
cytochrome bc1; DBH2, 2,3-dimethoxy-5-decyl-6-methyl-1,4-benzohydro-
quinone; 2Fe2S, two iron– two sulfur cluster; Rba., Rhodobacter
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gy, Krakow, Poland.permanently displace quinone substrates and make it
frustratingly impossible to observe and describe the natural
engineering of the Q site catalytic events themselves. To
date, no reversible inhibitors that bind outside the Qo and
Qi sites have been found.
Here, we borrow a page from classical cytochrome
oxidase inhibition studies and describe a novel way of
manipulating redox cofactor properties in cytochrome bc1.
We show that oxidized cytochrome c1 in the photosynthet-
ic bacterium Rhodobacter (Rba.) capsulatus cytochrome
bc1 reversibly binds cyanide (cyt c1-CN) with surprisingly
high affinity and this binding shifts the heme redox
midpoint potential dramatically. Such reversible inhibition
allows the dissection of sequential electron transfers to be
extended to the high-potential redox chain of cytochrome
bc1 without sabotaging Qo site activity.2. Materials and methods
Chromatophore membranes and cytochrome bc1 were
isolated and purified from Rba. capsulatus as described in
Refs. [10,11]. All experiments were performed in 50 mM
Tris–HCl, pH 8.0, 100 mM NaCl, at room temperature.
Optical spectra were recorded on a Perkin-Elmer UV/vis
Fig. 1. Sites of inhibition in high- and low-potential redox chains of
cytochrome bc1. Conventional quinonoid inhibitors specifically replace
quinones in the Qo site (stigmatellin, stg; myxothiazol, myx) or in the Qi
site (antymycin, ant). Binding of cyanide (CN) to oxidized cytochrome c1
introduces a new, Qo and Qi site-independent, site of inhibition.
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for c- and b-type cytochromes, samples were first oxidized
by an addition of potassium ferricyanide (to a final
concentration of 20 AM) and then reduced using sodium
ascorbate (added to a final concentration of 0.2 mM) or a
minimal amount of solid, fresh sodium dithionite. To
obtain difference spectra of cyanide-treated cytochrome
bc1, oxidized samples were first treated with excess of
KCN (see Fig. 3) and allowed to equilibrate with KCN for
5 h before ascorbate or dithionite was added.
To determine the binding constant for cyanide, the
ferricyanide-oxidized samples containing 5 AM of purified
cytochrome bc1 were incubated with various amounts of
KCN overnight to allow a relatively complete equilibration
of the protein with the ligand [12]. After this incubation,
the ascorbate minus ferricyanide optical redox difference
spectrum for each KCN concentration was obtained and
the fraction of ascorbate-reducible cytochrome c1 was
estimated from the amplitude of absorbance change 553–
540 nm in the a-region. Similar titrations were performed
with purified chromatophore membranes.
For observing the kinetics of cyanide release from cyt
c1-CN, a sample of 0.3 ml of oxidized cytochrome bc1
(30 AM) was equilibrated with excess of KCN (1 mM)
for 5 h. The sample was then passed through PD-10
desalting column (Pharmacia) equilibrated with 50 mM
Tris–HCl, pH 8, 100 mM NaCl. Following the removal
of excess of KCN, the sample was reduced with excess
ascorbate (added to a final concentration of 2 mM) and
the spectral changes in the a-region were recorded over
time to monitor the recovery of the ascorbate-reducible
component.Steady-state enzymatic activity of cytochrome bc1 was
assayed by measuring 2,3-dimethoxy-5-decyl-6-methyl-
1,4-benzohydroquinone (DBH2)-dependent reduction of
mitochondrial horse cytochrome c as described in Refs.
[10,13], and the rate of cytochrome c reduction was related
to the molar content of cytochrome c1. Activities were
assayed at room temperature in 50 mM Tris pH 8, 100
mM KCl, 0.1 g/l dodecyl maltoside with 8 nM cytochrome
bc1. For cyanide titration, samples containing 1.6 AM
cytochrome bc1 pre-incubated overnight without and with
increasing concentrations of KCN were considered stock
solutions for the enzymatic assay. In the assay, they were
added to the reaction mixture containing the same concen-
tration of KCN as that used in each stock solution.
Undiluted stock solutions were also used to determine
the amount of the cyt c1-CN bound form in the ascor-
bate-reducibility test, as described above.3. Results
Native cytochrome bc1 has three heme redox compo-
nents: high-potential heme c1 and two low-potential hemes
b, bL and bH. In Rba. capsulatus the redox potentials of
these hemes at pH 7 are: + 320 mV for heme c1, + 40 mV
for heme bH and  120 mV for heme bL [13]. The large
difference in the redox potentials between heme c1 and
hemes b allows us to perform simple tests for binding of
the cyanide with the use of oxidants and reductants that
distinguish between high- and low-potential redox compo-
nents: ferricyanide oxidizes all three heme components,
ascorbate reduces only heme c1, dithionite reduces both
hemes b in addition to heme c1.
Fig. 2 shows the effect of adding cyanide to fully
oxidized cytochrome bc1. The clear red shifts both in the
Soret and a-region with transitions at 403, 422, 521 and
548 nm are typical of cyanide binding to heme, while the
a-band changes around 550 nm indicate that cyanide binds
to oxidized heme c1 rather than either of the hemes b.
Indeed, the observation that ascorbate-reduced cytochrome
bc1 does not show spectral changes after addition of
cyanide (not shown) confirms that oxidized hemes b do
not bind cyanide.
The binding of cyanide to ferricytochrome c1 is
expected to have a large effect on the redox midpoint
potential of heme c1. The optical redox difference spectra
of isolated cytochrome bc1 shown in Fig. 3a,b reveal that
the cyt c1-CN indeed has a severely lowered redox
potential. The spectrum of the native form of the complex
is characterized by the presence of both ascorbate- and
dithionite-reducible components (Fig. 3a, dashed and solid
line, respectively). The binding of cyanide eliminates the
ascorbate-reducible component (Fig. 3b, dashed line) and
causes dithionite to reduce both hemes b prior to heme c1
(Fig. 3b, solid line). The shoulder at 552–554 nm in the
dithionite reduced spectrum, clearly seen in the native form
Fig. 3. Effect of cyanide on the redox properties of cytochrome c1 in
isolated cytochrome bc1 (a, b), and cytochromes c in chromatophores (c, d).
Ferricyanide oxidized samples were either untreated (a, c) or treated with 1
mM KCN (b, d) and then reduced by ascorbate or dithionite. Solid and
dashed lines correspond to dithionite minus ferricyanide and ascorbate
minus ferricyanide optical redox difference spectra, respectively.
Fig. 2. Cyanide-induced optical spectral changes in purified cytochrome
bc1. (a) Absorption spectra of ferricyanide oxidized bc1 before (solid line)
and after addition of 2 mM KCN (dashed line), (b) ferricyanide oxidized
minus ferricyanide oxidized-cyanide bound difference spectrum.
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cyanide only after initial reduction of hemes b and
prolonged incubation with dithionite (not shown). This
indicates that cyanide binds to the heme c1 reversibly
and lowers its midpoint potential dramatically, making it
much more difficult to reduce. Fig. 3c and d demonstrates
that cyanide has the same effect on the redox properties of
cytochrome bc1 in chromatophore membranes. Because no
c-type absorption spectrum appears in cyanide and ascor-
bate treated chromatophores (Fig. 3d, dashed line), cyanide
is likely to interfere with the ascorbate reducibility of all
the high potential c-type cytochromes in chromatophores,
including cytochrome c2 and cy. This would agree with the
earlier observations that some bacterial cytochromes c
display a much more increased propensity to bind exoge-
nous strong field ligands than their mitochondrial counter-
parts [14,15] (see discussion below).
The cyanide-induced shift in the redox potential of
cytochrome c1 was used to estimate the binding constant
(Kd) for cyanide. This approach combined the titration of
cytochrome c1 with cyanide with the ascorbate reducibility
test, and was based on the assumption that ascorbate
reduces only that portion of cytochrome c1 that did not
bind cyanide when ferricytochrome c1 was exposed to
react with it. Thus, in the effective range of cyanideconcentrations, the amount of ascorbate-reducible cyto-
chrome c1 will depend on the concentration of cyanide
used. As shown in Fig. 4, the fraction of ascorbate-
reducible cytochrome c1 (i.e. fraction of the ‘‘free’’ form)
decreases with increasing amount of cyanide and the
titration profile allows us to estimate a Kd of approxi-
mately 25 AM for isolated cytochrome bc1, and a similar
value for chromatophores. It should be noted that our
initial experiments showed that the binding of cyanide is
very slow and occurs within hours (data not shown).
Therefore, an extended overnight incubation with cyanide
was allowed before the ascorbate reduction to assure more
or less complete equilibration for all but the smallest
cyanide concentrations.
The ascorbate-reducibility test was also used to monitor
the kinetics of release of cyanide from cyt c1-CN. In this
assay, the recovery of the cytochrome c1 ascorbate reduc-
ibility occurs parallel to the release of cyanide from the
heme-binding pocket. The time-course of this process is
shown in Fig. 5. Given that the kinetics of cyanide binding/
release is much slower that the reduction of cytochrome c1
by ascorbate, we estimate the koff of 0.0019 min
 1 for the
release of cyanide. This koff value and the Kd of 25 10 6
M, gives the second-order rate of binding of cyanide to
cytochrome c1, kon, of 1.2 M
 1 s 1.
Fig. 4. Determination of the binding constant for cyanide in oxidized
cytochrome c1 in isolated bc1 complexes (a) and chromatophores (b) using
the ascorbate reduction assay described in materials and methods. Fractions
of ascorbate non-reducible cytochrome c1 with bound cyanide (cyt c1-CN)
are plotted versus the concentration of cyanide.
Fig. 6. Effect of cyanide on the enzymatic ubiquinol-cytochrome c
reductase activity of cytochrome bc1. Activities are expressed as a
percentage of the activity without inhibitor (measured turnover rate 210
s 1) and plotted versus the fraction of cyt c1-CN (bound form) in the
samples used in the assay.
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reductase activity by cyanide in an enzymatic steady-state
turnover assay using catalytic amounts of purified cyto-
chrome bc1. The activity of the enzyme decreases linearly
with increasing concentration of cyt c1-CN form with a
slight deviation from the linearity at low concentrations of
cyanide (below 10 AM). However, cyanide does notFig. 5. Kinetics of cyanide release from cytochrome c1 in isolated bc1
complexes monitored as a recovery of ascorbate-reducible component (asc
red cyt c1) (553–540 nm) in the spectrum.completely inhibit the enzymatic activity of cytochrome
bc1; even at high concentrations of cyanide (where the
concentration of cyt c1-CN is maximal), a significant
(22%) activity of the complex is observed. For compari-
son, only 2% activity is observed when cytochrome bc1 is
fully inhibited with antimycin.4. Discussion
Bacterial cytochrome bc1 displays a high degree of
homology with mitochondrial complex III. In both sys-
tems, three redox cofactor containing subunits, cyto-
chrome c1, 2Fe–2S subunit and cytochrome b, form
similarly assembled and operating catalytic core. Within
this core, the two quinol/quinone binding sites, by pro-
viding an environment for catalytic chemical reactions
and defining critically important, but different levels of
stability for the semiquinone state, are expected to display
the highest degree of structural conservation among
various species. On the other hand, the parts more remote
from the quinone binding sites may have larger degree of
conformational freedom allowing some structural variation
among species to occur. Indeed, the most significant
differences can be found within the most peripheral
subunit, cytochrome c1, which interacts directly only with
the physiological partners of cytochrome bc1 (like cyto-
chromes c) and the mobile 2Fe–2S domain (Fig. 1). For
example, some bacterial cytochromes c1 have additional
structure–function related insertions in the loop regions,
while the homologous cytochrome b6f in chloroplasts,
replaces the entire cytochrome c1 with structurally differ-
ent cytochrome f. Recently, we have recognized that
cytochrome c1 of the photosynthetic bacterium Rba.
capsulatus has an unusual structural characteristic relying
on a disulfide bond to maintain the proper heme axial
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[16]. Such structural variability in cytochrome c1 may be
at the root of differences in cyanide sensitivity; bovine
mitochondrial cytochrome bc1 does not bind cyanide even
at very high levels (Rich, P.R., University College Lon-
don, personal communication).
The behavior of Rba. capsulatus cytochrome c1 is
consistent with a model in which an added ligand binds to
the heme iron by displacing one of its native coordinating
ligands [14,15,17–19]. In cytochrome c, the transition from
reduced to oxidized form is known to involve a dynamic
rearrangement which weakens the strength of methionine
sixth axial ligation and permits its replacement by exoge-
nous strong field ligands. This site is therefore the most
plausible region of interaction of cytochrome c1 with
cyanide. Such perturbation of heme axial ligation correlates
with a decrease of hundreds of mV in the redox potential of
cyt c1-CN (Fig. 3) in analogy with cyanide-induced mid-
point drops in other heme proteins [20,21]. The perturba-
tion, however, does not cause an irreversible damage to the
protein; the release of cyanide in experimental conditions of
Fig. 5 restores the native spectral and redox properties of
cytochrome c1 as indicated by the recovery of the native-like
ascorbate-reducible component in the spectrum of cyto-
chrome bc1 (not shown).
The propensity to bind exogenous strong field ligands
observed in certain other cytochromes c (in particular
bacterial cytochromes c2) has been related to the dynamic
process of the opening of the heme crevice to vacate the
sixth coordination for interaction with exogenous ligands
[14,15]. The rapid interconversion between the closed and
opened forms is probably part of the natural protein
dynamics and originates largely from the increased con-
formational mobility of the sixth axial ligand domain. In
Rba. capsulatus cytochrome c1, this region encompasses
the disulfide anchored extra loop, which appears to control
the integrity of the heme-binding pocket and secure the
proper heme axial ligation [16]. Such a strategy for
governing heme-ligand reactivity and conformational sta-
bility has not been seen in other c-type cytochromes and
may be one of the factors responsible for the unusual
ligand binding properties of this cytochrome. Moreover,
the cyanide binding and release of cytochrome c1 are
extremely slow indicating that, despite its apparent acces-
sibility for the external ligand, the heme coordination site
remains severely hindered. The disulfide-anchored loop
may provide a steric barrier that protects the interior of
the heme-binding pocket, yet has some degree of mobility
allowing limited access from outside.
Despite a cyanide-induced cytochrome c1 redox mid-
point potential drop below ascorbate reducibility, which
makes 2Fe2S to cyt c1-CN electron transfer energetically
unfavorable, steady-state ubiquinol/cytochrome c oxidore-
ductase activity is still observable at approximately 20% of
native activity. This activity occurs even when essentially
all cytochrome c1 exhibits the spectral signature of cyt c1-CN. Clearly, under steady-state conditions Qo site reduced
2Fe2S is capable of defeating the cyanide inhibition.
It is conceivable that cyanide bound to heme c1 might
briefly and incompletely dissociate from oxidized heme
c1 on the time scale of catalytic turnover, analogous to
classic photo-dissociated heme ligands that remain near
the heme pocket and re-associate relatively quickly (for
example, see Ref. [22]). This might enable normal 2Fe2S
to heme c1 electron transfer, albeit at reduced rates.
However, under these circumstances, dissociated cyanide
would have to stand ready to rebind quickly to cyto-
chrome c1, when reoxidized by cytochrome c, to continue
inhibition of turnover. This rebinding would have to be
much faster than the binding rates we measure from free
solution.
However, we favor an alternative in which energetically
unfavorable electron transfer from 2Fe2S to cyt c1-CN
may occur without cyanide dissociation. Analogous elec-
trochemical reduction of CN-bound heme has been probed
by cyclic voltammetry with myoglobin [20]. Redox mid-
point potentials for the CN-bound and CN-free myoglobin
heme were resolved, and redox associated cyanide disso-
ciation and association rates were measured. In cytochrome
bc1, the rate of the uphill electron transfer from 2Fe2S to
cyt c1-CN will depend on the redox potential of cyt c1-CN
and the inherent rate of the downhill electron transfer from
cyt c1-CN to 2Fe2S. The rate of native electron transfer
between 2Fe2S and cytochrome c1 has been reported to
range from roughly 60,000 to 6000 s 1 [23], with the
latter rate consistent with the 16 A˚ tunneling distance at
closest approach in bc1 crystals, assuming typical reorga-
nization energies [24]. An energetic penalty for the 2Fe2S
to cyt c1-CN reaction of 2.2–3.2 orders of magnitude
(130–200 mV) is required to slow the rate to our inhibited
steady-state value of about 40 s-1. The corresponding cyt
c1-CN redox midpoint potentials in the range of 80–150
mV are just what is required to make ascorbate reduction
unfavorable.
The binding of cyanide to the native ferricytochrome c1
of Rba. capsulatus cytochrome bc1 is a curiously late
finding, and provides a caution to those who view cyanide
as a simple selective means for cytochrome oxidase
inhibition, especially at high cyanide concentrations. Cya-
nide provides the first cytochrome bc1 inhibitor outside the
Qo and Qi ubiquinone sites, and its reversibility promises
to be a useful tool to manipulate the extended high-
potential electron transfer chains in cytochrome bc1 to
investigate the dynamics of Qo site catalysis and 2Fe2S
motion in this key component of photosynthetic and
respiratory chains.Acknowledgements
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